Xuancheng Menovo Pharmaceutical Co., Ltd. is a wholly-owned subsidiary invested and established by the group in 2015. The company has a total land area of approximately 150,000 square meters and it is built to become a new automated closed pipeline manufacturing base for APIs and intermediates. With advanced utility system, excellent EHS systems and production system covering a variety of synthetic reactions, it provides customers with comprehensive API solutions and successfully builds an API production base with international EHS and quality standards compliance. It produces high-value-added and high-tech APIs and intermediates, providing a reliable source for the development of downstream formulations. Also it provides CMO/CDMO services.